Cargando…

Prevalence of Anemia Among Gynecologic Cancer Patients Who Received Chemotherapy, Radiotherapy, or a Combination of Both at King Abdulaziz Medical City, Jeddah

Objective: The aim of this study is to calculate hemoglobin (Hb) levels and find the prevalence of anemia in gynecological cancer patients undergoing cancer treatments including chemotherapy and radiotherapy attending Princess Noorah Oncology Center in King Abdul Aziz Medical City in Jeddah. Method:...

Descripción completa

Detalles Bibliográficos
Autores principales: Alghamdi, Atheer H, Niyaz, Rahaf I, Al-Jifree, Hatim, Khan, Muhammad A, Alsalmi, Lamyaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483600/
https://www.ncbi.nlm.nih.gov/pubmed/34646664
http://dx.doi.org/10.7759/cureus.17613
_version_ 1784577161336717312
author Alghamdi, Atheer H
Niyaz, Rahaf I
Al-Jifree, Hatim
Khan, Muhammad A
Alsalmi, Lamyaa
author_facet Alghamdi, Atheer H
Niyaz, Rahaf I
Al-Jifree, Hatim
Khan, Muhammad A
Alsalmi, Lamyaa
author_sort Alghamdi, Atheer H
collection PubMed
description Objective: The aim of this study is to calculate hemoglobin (Hb) levels and find the prevalence of anemia in gynecological cancer patients undergoing cancer treatments including chemotherapy and radiotherapy attending Princess Noorah Oncology Center in King Abdul Aziz Medical City in Jeddah. Method: A cross-sectional chart review study was conducted in gynecological cancer patients receiving chemotherapy/radiotherapy to find the prevalence of anemia in the period between 2016 and 2018. All data were collected from the electronic medical records using a data collection sheet. Results: A total of 107 female patients who had gynecologic cancers and received chemotherapy/radiotherapy were included. Ninety percent (90.7%) of them developed anemia during the treatment course. Conclusion: The prevalence of anemia in patients with gynecological cancers during their active treatment was high. This is attributed to the chemotherapy and radiotherapy they were receiving that affected their Hb levels. Better monitoring and, in severe cases, blood transfusion could be beneficial.
format Online
Article
Text
id pubmed-8483600
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-84836002021-10-12 Prevalence of Anemia Among Gynecologic Cancer Patients Who Received Chemotherapy, Radiotherapy, or a Combination of Both at King Abdulaziz Medical City, Jeddah Alghamdi, Atheer H Niyaz, Rahaf I Al-Jifree, Hatim Khan, Muhammad A Alsalmi, Lamyaa Cureus Obstetrics/Gynecology Objective: The aim of this study is to calculate hemoglobin (Hb) levels and find the prevalence of anemia in gynecological cancer patients undergoing cancer treatments including chemotherapy and radiotherapy attending Princess Noorah Oncology Center in King Abdul Aziz Medical City in Jeddah. Method: A cross-sectional chart review study was conducted in gynecological cancer patients receiving chemotherapy/radiotherapy to find the prevalence of anemia in the period between 2016 and 2018. All data were collected from the electronic medical records using a data collection sheet. Results: A total of 107 female patients who had gynecologic cancers and received chemotherapy/radiotherapy were included. Ninety percent (90.7%) of them developed anemia during the treatment course. Conclusion: The prevalence of anemia in patients with gynecological cancers during their active treatment was high. This is attributed to the chemotherapy and radiotherapy they were receiving that affected their Hb levels. Better monitoring and, in severe cases, blood transfusion could be beneficial. Cureus 2021-08-31 /pmc/articles/PMC8483600/ /pubmed/34646664 http://dx.doi.org/10.7759/cureus.17613 Text en Copyright © 2021, Alghamdi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Obstetrics/Gynecology
Alghamdi, Atheer H
Niyaz, Rahaf I
Al-Jifree, Hatim
Khan, Muhammad A
Alsalmi, Lamyaa
Prevalence of Anemia Among Gynecologic Cancer Patients Who Received Chemotherapy, Radiotherapy, or a Combination of Both at King Abdulaziz Medical City, Jeddah
title Prevalence of Anemia Among Gynecologic Cancer Patients Who Received Chemotherapy, Radiotherapy, or a Combination of Both at King Abdulaziz Medical City, Jeddah
title_full Prevalence of Anemia Among Gynecologic Cancer Patients Who Received Chemotherapy, Radiotherapy, or a Combination of Both at King Abdulaziz Medical City, Jeddah
title_fullStr Prevalence of Anemia Among Gynecologic Cancer Patients Who Received Chemotherapy, Radiotherapy, or a Combination of Both at King Abdulaziz Medical City, Jeddah
title_full_unstemmed Prevalence of Anemia Among Gynecologic Cancer Patients Who Received Chemotherapy, Radiotherapy, or a Combination of Both at King Abdulaziz Medical City, Jeddah
title_short Prevalence of Anemia Among Gynecologic Cancer Patients Who Received Chemotherapy, Radiotherapy, or a Combination of Both at King Abdulaziz Medical City, Jeddah
title_sort prevalence of anemia among gynecologic cancer patients who received chemotherapy, radiotherapy, or a combination of both at king abdulaziz medical city, jeddah
topic Obstetrics/Gynecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483600/
https://www.ncbi.nlm.nih.gov/pubmed/34646664
http://dx.doi.org/10.7759/cureus.17613
work_keys_str_mv AT alghamdiatheerh prevalenceofanemiaamonggynecologiccancerpatientswhoreceivedchemotherapyradiotherapyoracombinationofbothatkingabdulazizmedicalcityjeddah
AT niyazrahafi prevalenceofanemiaamonggynecologiccancerpatientswhoreceivedchemotherapyradiotherapyoracombinationofbothatkingabdulazizmedicalcityjeddah
AT aljifreehatim prevalenceofanemiaamonggynecologiccancerpatientswhoreceivedchemotherapyradiotherapyoracombinationofbothatkingabdulazizmedicalcityjeddah
AT khanmuhammada prevalenceofanemiaamonggynecologiccancerpatientswhoreceivedchemotherapyradiotherapyoracombinationofbothatkingabdulazizmedicalcityjeddah
AT alsalmilamyaa prevalenceofanemiaamonggynecologiccancerpatientswhoreceivedchemotherapyradiotherapyoracombinationofbothatkingabdulazizmedicalcityjeddah